| Literature DB >> 32003296 |
David M Kessler1, Saradha Ananthakrishnan2, Spencer B Smith3, Kristen D'Onofrio1, René H Gifford1,4.
Abstract
Multiple studies have shown significant speech recognition benefit when acoustic hearing is combined with a cochlear implant (CI) for a bimodal hearing configuration. However, this benefit varies greatly between individuals. There are few clinical measures correlated with bimodal benefit and those correlations are driven by extreme values prohibiting data-driven, clinical counseling. This study evaluated the relationship between neural representation of fundamental frequency (F0) and temporal fine structure via the frequency following response (FFR) in the nonimplanted ear as well as spectral and temporal resolution of the nonimplanted ear and bimodal benefit for speech recognition in quiet and noise. Participants included 14 unilateral CI users who wore a hearing aid (HA) in the nonimplanted ear. Testing included speech recognition in quiet and in noise with the HA-alone, CI-alone, and in the bimodal condition (i.e., CI + HA), measures of spectral and temporal resolution in the nonimplanted ear, and FFR recording for a 170-ms/da/stimulus in the nonimplanted ear. Even after controlling for four-frequency pure-tone average, there was a significant correlation (r = .83) between FFR F0 amplitude in the nonimplanted ear and bimodal benefit. Other measures of auditory function of the nonimplanted ear were not significantly correlated with bimodal benefit. The FFR holds potential as an objective tool that may allow data-driven counseling regarding expected benefit from the nonimplanted ear. It is possible that this information may eventually be used for clinical decision-making, particularly in difficult-to-test populations such as young children, regarding effectiveness of bimodal hearing versus bilateral CI candidacy.Entities:
Keywords: bimodal benefit; bimodal hearing; cochlear implants; electrophysiology; hearing aids
Mesh:
Year: 2020 PMID: 32003296 PMCID: PMC7257083 DOI: 10.1177/2331216520902001
Source DB: PubMed Journal: Trends Hear ISSN: 2331-2165 Impact factor: 3.293
Demographic Information.
| Subject number | Age at testing (years) | Ear implanted | Gender | Implant manufacturer | Device, electrode type | Years of CI use | Aided SII at 60 dB SPL | Full-time hearing aid user? |
|---|---|---|---|---|---|---|---|---|
| 1 | 54.51 | Left | Female | MED-EL | Concert, Standard | 3.91 | NA | Yes |
| 2 | 70.31 | Right | Female | AB | HiRes Ultra, mid-scala | 1.20 | 29 | Yes |
| 3 | 62.17 | Right | Female | Cochlear | CI24RE, L24 | 1.00 | 21 | Yes |
| 4 | 40.33 | Left | Female | Cochlear | Profile, CI532 | 0.73 | 16 | No |
| 5 | 74.12 | Left | Female | MED-EL | Synchrony, FLEX28 | 0.78 | 34 | Yes |
| 6 | 79.28 | Left | Male | Cochlear | CI24RE, contour advance | 5.95 | 11 | Yes |
| 7 | 46.65 | Right | Female | AB | HiRes 90K Advantage, Mid-Scala | 3.10 | 34 | Yes |
| 8 | 63.87 | Left | Female | MED-EL | Synchrony, FLEX24 | 1.00 | 23 | No |
| 9 | 36.10 | Right | Female | AB | HiRes Ultra, Mid-Scala | 0.93 | 37 | Yes |
| 10 | 64.64 | Right | Male | AB | HiRes 90K Advantage, 1j | 5.76 | 48 | Yes |
| 11[ | 56.87 | Left | Female | AB | HiRes 90K Advantage, Mid-Scala | 4.66 | 30 | Yes |
| 12[ | 79.44 | Left | Male | Cochlear | Profile, CI512 | 0.86 | 74 | Yes |
| 13 | 25.01 | Right | Female | Cochlear | CI24RE, contour advance | 10.60 | 53 | Yes |
| 14 | 55.59 | Right | Female | AB | HiRes Ultra, Mid-Scala | 1.45 | 38 | Yes |
Note. Age at testing, ear implanted, gender, implant manufacturer, electrode type, years of CI use, aided SII in the nonimplanted ear, and full-time HA user at the time of testing. NA = not applicable; AB = Advanced Bionics.
aParticipant’s FFR data were not included due to experimenter error during stimulus presentation.
Figure 1.Audiometric thresholds (dB HL) in the nonimplanted ear from 125 to 8000 Hz for each participant.
Figure 2.Speech recognition scores (rau) for CNC (a), AzBio sentences in +5 dB SNR (S0N0) (b), and AzBio sentences in +5 dB SNR (S0N45–315) (c) listening with the CI-only (x-axis) and in the bimodal condition (y-axis). See the main text for further details. CNC = consonant–nucleus–consonant; CI = cochlear implant; HA = hearing aid.
Figure 3.Average acoustic benefit (a) measured in rau and normalized acoustic benefit (b) measured in percent for CNC words in quiet, AzBio sentences at +5 dB SNR (S0N0 and S0N45–315). Error bars represent ± 1 standard deviation. CNC = consonant–nucleus–consonant.
Correlation Coefficients for Measures of Acoustic Benefit and Audiometric Threshold at 125 Hz, Four-Frequency PTA (0.5, 1, 2, and 4 kHz), Aided SII, and Age at Testing.
| Measures | CNC | AzBio +5 dB SNR S0N0 | AzBio +5 dB SNR S0N45–315 |
|---|---|---|---|
| Audiometric threshold at 125 Hz | 0.31 ( | 0.69 ( | 0.12 ( |
| Four-frequency PTA (0.5, 1, 2, and 4 kHz) | 0.4 ( | 0.01 ( | 0.09 ( |
| Aided SII | 0.25 ( | 0.07 ( | 0.01 ( |
| Age at testing | 0.14 ( | 0.50 ( | 0.15 ( |
CNC = consonant–nucleus–consonant; SII = speech intelligibility index; PTA = pure-tone average; SNR = signal-to-noise ratio.
Correlation Coefficients for Measures of Normalized Acoustic Benefit and Audiometric Threshold at 125 Hz, Four-Frequency PTA (0.5, 1, 2, and 4 kHz), Aided SII, and Age at Testing.
| Measures | CNC | AzBio +5 dB SNR S0N0 | AzBio +5 dB SNR S0N45–315 |
|---|---|---|---|
| Audiometric threshold at 125 Hz | 0.06 ( | 0.59 ( | 0.11 ( |
| Four-frequency PTA (0.5, 1, 2, and 4 kHz) | 0.35 ( | 0.05 ( | 0.10 ( |
| Aided SII | 0.36 ( | 0.11 ( | 0.19 ( |
| Age at testing | 0.20 ( | 0.66 ( | 0.23 ( |
CNC = consonant–nucleus–consonant; SII = speech intelligibility index; PTA = pure-tone average; SNR = signal-to-noise ratio.
Figure 4.Grand average envelope FFR waveform (a), grand average fine structure FFR waveform (b), FFR envelope spectrum (c), and FFR fine structure spectrum (d). Note that the envelope and fine structure spectra were calculated over the steady state (60–180 ms) range of the response waveform. Shaded regions represent SEM. Arrows point to amplitude at F0 (100 Hz; c) and F1 (700 Hz; d).
Figure 5.Acoustic benefit (left column) measured in rau and normalized acoustic benefit (right column) measured in percent for CNC words (a and b), AzBio sentences in +5 dB SNR (S0N0) (c and d), and AzBio sentences in +5 dB SNR (S0N45–315) (e and f) as a function of envelope spectrum amplitude of the frequency following response at the fundamental frequency (F0, 100 Hz). CNC = consonant–nucleus–consonant.